Related references
Note: Only part of the references are listed.The role of antigen-presenting cells in filoviral hemorrhagic fever: Gaps in current knowledge
Osvaldo Martinez et al.
ANTIVIRAL RESEARCH (2012)
Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012)
M. J. Adams et al.
ARCHIVES OF VIROLOGY (2012)
Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice
Mark S. Lever et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
Andrea Marzi et al.
PLOS ONE (2012)
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
John M. Dye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
Xiangguo Qiu et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
Xiangguo Qiu et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies
Xiangguo Qiu et al.
CLINICAL IMMUNOLOGY (2011)
Filovirus vaccines
Steven B. Bradfute et al.
HUMAN VACCINES (2011)
Protective Role of Cytotoxic T Lymphocytes in Filovirus Hemorrhagic Fever
Kelly Lyn Warfield et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Protective Efficacy of a Bivalent Recombinant Vesicular Stomatitis Virus Vaccine in the Syrian Hamster Model of Lethal Ebola Virus Infection
Yoshimi Tsuda et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Assessment of Rodents as Animal Models for Reston Ebolavirus
Emmie de Wit et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Filovirus Infection of STAT-1 Knockout Mice
JoLynne Raymond et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Key Genomic Changes Necessary for an In Vivo Lethal Mouse Marburgvirus Variant Selection Process
Loreen L. Lofts et al.
JOURNAL OF VIROLOGY (2011)
Marburg Virus VP40 Antagonizes Interferon Signaling in a Species-Specific Manner
Charalampos Valmas et al.
JOURNAL OF VIROLOGY (2011)
Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology
Douglas S. Reed et al.
MICROBES AND INFECTION (2011)
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice
Krishnamurthy Konduru et al.
VACCINE (2011)
A small nonhuman primate model for filovirus-induced disease
Ricardo Carrion et al.
VIROLOGY (2011)
Correlates of Immunity to Filovirus Infection
Steven B. Bradfute et al.
VIRUSES-BASEL (2011)
Filoviral Immune Evasion Mechanisms
Parameshwaran Ramanan et al.
VIRUSES-BASEL (2011)
EVALUATION OF PERCEIVED THREAT DIFFERENCES POSED BY FILOVIRUS VARIANTS
Jens H. Kuhn et al.
BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE (2011)
Antiviral Activity of a Small-Molecule Inhibitor of Filovirus Infection
Travis K. Warren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
Jens H. Kuhn et al.
ARCHIVES OF VIROLOGY (2010)
Mechanisms and Consequences of Ebolavirus-Induced Lymphocyte Apoptosis
Steven B. Bradfute et al.
JOURNAL OF IMMUNOLOGY (2010)
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Thomas W. Geisbert et al.
LANCET (2010)
Advanced antisense therapies for postexposure protection against lethal filovirus infections
Travis K. Warren et al.
NATURE MEDICINE (2010)
Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
Nadia Wauquier et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection
Dana L. Swenson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Development of a broad-spectrum antiviral with activity against Ebola virus
M. Javad Aman et al.
ANTIVIRAL RESEARCH (2009)
Reduced Levels of Protein Tyrosine Phosphatase CD45 Protect Mice from the Lethal Effects of Ebola Virus Infection
Rekha G. Panchal et al.
CELL HOST & MICROBE (2009)
Reduced Expression of CD45 Protein-tyrosine Phosphatase Provides Protection against Anthrax Pathogenesis
Rekha G. Panchal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever
Kelly L. Warfield et al.
JOURNAL OF VIROLOGY (2009)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
Tina Branscombe Miranda et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
Alexander Bukreyev et al.
VIROLOGY (2009)
Protection against lethal challenge by Ebola virus-like particles produced in insect cells
Yuliang Sun et al.
VIROLOGY (2009)
Discovery of common marburgvirus protective epitopes in a BALB/c mouse model
Warren V. Kalina et al.
VIROLOGY JOURNAL (2009)
Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses
Kevin B. Spurgers et al.
ANTIVIRAL RESEARCH (2008)
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections
Dana L. Swenson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Functional CD8+ T cell responses in lethal Ebola virus infection
Steven B. Bradfute et al.
JOURNAL OF IMMUNOLOGY (2008)
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2008)
Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
Maria A. Croyle et al.
PLOS ONE (2008)
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
Thomas W. Geisbert et al.
VACCINE (2008)
Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin a proteins with activated STAT1
St. Patrick Reid et al.
JOURNAL OF VIROLOGY (2007)
Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice
Ami Patel et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: Identification of alleles associated with fatal and nonfatal disease outcomes
Anthony Sanchez et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Marburg virus Angola infection of rhesus macaques: Pathogenesis and treatment with recombinant nematode anticoagulant protein c2
Thomas W. Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever
Lisa E. Hensley et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates
Peter B. Jahrling et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever
Steven M. Jones et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Lymphocyte death in a mouse model of Ebola virus infection
Steven B. Bradfute et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Development of a model for marburgvirus based on severe-combined immunodeficiency mice
Kelly L. Warfield et al.
VIROLOGY JOURNAL (2007)
Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro
Manisha Gupta et al.
VIROLOGY (2007)
Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens
Soraya Shahhosseini et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Successful topical respiratory tract immunization of primates against ebola virus
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2007)
Humanized mice in translational biomedical research
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections
Janie Parrino et al.
EMERGING INFECTIOUS DISEASES (2007)
Protective efficacy of neutralizing antibodies against Ebola virus infection
Ayato Takada et al.
VACCINE (2007)
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
Wendelien B. Oswald et al.
PLOS PATHOGENS (2007)
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
Julie E. Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine
Kathleen M. Daddario-DiCaprio et al.
JOURNAL OF VIROLOGY (2006)
Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges
Danher Wang et al.
VIROLOGY (2006)
Molecular determinants of Ebola virus virulence in mice
Hideki Ebihara et al.
PLOS PATHOGENS (2006)
Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference
Thomas W. Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J. Sullivan et al.
PLOS MEDICINE (2006)
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates:: an efficacy assessment
KM Daddario-DiCaprio et al.
LANCET (2006)
De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses
DH Wang et al.
VACCINE (2006)
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus
GP Kobinger et al.
VIROLOGY (2006)
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice
S Enterlein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge
A Bukreyev et al.
JOURNAL OF VIROLOGY (2006)
Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers
Kelly L. Warfield et al.
PLOS PATHOGENS (2006)
Protective cytotoxic T-cell responses induced by Venezuelan equine encephalitis virus replicons expressing Ebola virus proteins
GG Olinger et al.
JOURNAL OF VIROLOGY (2005)
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection
KL Warfield et al.
JOURNAL OF IMMUNOLOGY (2005)
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
DL Swenson et al.
VACCINE (2005)
CD8-mediated protection against Ebola virus infection is perforin dependent
M Gupta et al.
JOURNAL OF IMMUNOLOGY (2005)
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses
M Garbutt et al.
JOURNAL OF VIROLOGY (2004)
Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein
DL Swenson et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
Identification of murine T-cell epitopes in Ebola virus nucleoprotein
G Simmons et al.
VIROLOGY (2004)
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection
KL Warfield et al.
VACCINE (2004)
Role of natural killer cells in innate protection against lethal Ebola virus infection
KL Warfield et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Persistent infection with Ebola virus under conditions of partial immunity
M Gupta et al.
JOURNAL OF VIROLOGY (2004)
Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: Cellular responses, virus load, and nitric oxide levels
A Sanchez et al.
JOURNAL OF VIROLOGY (2004)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys
TW Geisbert et al.
LANCET (2003)
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques - Evidence that dendritic cells are early and sustained targets of infection
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Pathogenesis of Ebola hemorrhagic fever in primate models - Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event
TW Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes
M Hevey et al.
VIROLOGY (2003)
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus
J Riemenschneider et al.
VACCINE (2003)
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
NJ Sullivan et al.
NATURE (2003)
Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection
S Mahanty et al.
VIROLOGY (2003)
Antibody-dependent enhancement of Ebola virus infection
A Takada et al.
JOURNAL OF VIROLOGY (2003)
Vaccine research efforts for filoviruses
MK Hart
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus
LG Barrientos et al.
ANTIVIRAL RESEARCH (2003)
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications
A Takada et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
Induction of immune responses in mice and monkeys to ebola virus after immunization with liposome-encapsulated irradiated ebola virus:: Protection in mice requires CD4+ T cells
M Rao et al.
JOURNAL OF VIROLOGY (2002)
3-deazaneplanocin A induces massively increased interferon-α production in Ebola virus-infected mice
M Bray et al.
ANTIVIRAL RESEARCH (2002)
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody
PWHI Parren et al.
JOURNAL OF VIROLOGY (2002)
Inflammatory responses in Ebola virus-infected patients
S Baize et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses
S Bavari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily
LE Hensley et al.
IMMUNOLOGY LETTERS (2002)
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses
P Pushko et al.
JOURNAL OF VIROLOGY (2001)
Marburg virus vaccines: comparing classical and new approaches
M Hevey et al.
VACCINE (2001)
Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice
TR Gibb et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2001)
Vaccine potential of Ebola virus VP24, VP30, VP36, and VP40 proteins
JA Wilson et al.
VIROLOGY (2001)
The role of the Type I interferon response in the resistance of mice to filovirus infection
M Bray
JOURNAL OF GENERAL VIROLOGY (2001)
Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication
M Gupta et al.
JOURNAL OF VIROLOGY (2001)
Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein
JA Wilson et al.
JOURNAL OF VIROLOGY (2001)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus
P Pushko et al.
VACCINE (2000)
Epitopes involved in antibody-mediated protection from Ebola virus
JA Wilson et al.
SCIENCE (2000)
Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor
M Bray et al.
ANTIVIRAL RESEARCH (2000)
Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?
S Baize et al.
APOPTOSIS (2000)
Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses
TW Geisbert et al.
LABORATORY INVESTIGATION (2000)
Share Paper
